Alfa Thermodiagnostics, Inc. has engineered a next-generation Whole-Body Thermometry system intended for measuring temperature differences in the skin surface temperatures only.  The AlfaSight 9000™ is grounded in the established science of Regulation Thermography which was invented and first commercialized in Germany more than 20 years ago. It is a proven, accurate technology supported by more than 100,000 patient measurements.

Dr. Daniel Beilin led the US FDA clearance of first-generation Regulation Thermography technology in 1996 and has now successfully led Alfa’s Infared upgraded system. He is recognized worldwide as the foremost authority on Whole-Body Thermometry, and is supported by leaders in the fields of Radiology, Neurobiology, and Regulation Medicine.

The AlfaSight 9000™ is a non-invasive patient assessment tool that identifies skin temperature changes before and after a cool-air stress is applied.